UNITED THERAPEUTICS Corp
Nasdaq · Healthcare · Pharmaceutical Preparations · Silver Spring, MD
UTHR chart
What traders are saying about $UTHR
Latest postsUNITED THERAPEUTICS Corp news
- Liquidia (NASDAQ:LQDA) Posts YUTREPIA Revenue Beat but EPS Miss and United Therapeutics Settlement
ChartMill ·
- Rochester now has a xenotransplant facility in its backyard. Experts say this field is primed for progress
Post Bulletin ·
- Liquidia Corporation Reports Third Quarter 2026 Financial Results
Yahoo Finance ·
- What State Street SPDR S&P MidCap 400 ETF (MDY) Sold: TechnipFMC Leads on Friday
Yahoo Finance ·
- United Therapeutics (UTHR) Stock Still Looks Like A Bargain As Its 184% Run Continues
Simply Wall St ·
- Martine Rothblatt, United Therapeutics CEO, sells $5.36M in shares By Investing.com
Investing.com India ·
- Liquidia (LQDA) Stock Looks Rich Relative To Its Earnings Power
Yahoo Finance ·
- Form 4 United Therapeutics Corporation: Martine A. Rothblatt (Director, Chairperson & CEO) For: 6 November
Investing.com Canada ·
- United Therapeutics Corp (UTHR) Shares Surge 3.6% -- What GF Score of 90 Tells Investors
GuruFocus ·
- United Therapeutics Insider Sold Shares Worth $5,362,824, According to a Recent SEC Filing
www.marketscreener.com ·
- After exercising options at $117.76 a share, United Therapeutics (UTHR) CEO trust sells 9,500 shares.
Stock Titan ·
- DraftKings downgraded, AMD upgraded: Wall Street's top analyst calls
Yahoo Finance ·
UNITED THERAPEUTICS Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.18B | $2.88B | $2.33B | $1.94B |
| Net income | $1.33B | $1.20B | $984.8M | $727.3M |
| Diluted EPS | $27.86 | $24.64 | $19.81 | $15.00 |
| Total assets (year end) | $7.88B | $7.36B | $7.17B | $6.04B |
| Cash and equivalents (year end) | $1.56B | $1.70B | $1.21B | $961.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About UNITED THERAPEUTICS Corp
- Ticker
- UTHR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Silver Spring, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1082554
Frequently asked questions
What exchange is UNITED THERAPEUTICS Corp listed on?
UNITED THERAPEUTICS Corp trades on the Nasdaq under the ticker symbol UTHR.
What industry is UNITED THERAPEUTICS Corp in?
UNITED THERAPEUTICS Corp is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is UNITED THERAPEUTICS Corp headquartered?
UNITED THERAPEUTICS Corp's business address on file with the SEC is in Silver Spring, MD.
When does UNITED THERAPEUTICS Corp's fiscal year end?
UNITED THERAPEUTICS Corp's fiscal year ends on December 31.
How much revenue did UNITED THERAPEUTICS Corp report?
UNITED THERAPEUTICS Corp reported $3.18B in revenue for calendar year 2025, according to its SEC filings.